Encompass Health Corp·4

Feb 20, 3:43 PM ET

Price Andrew L 4

4 · Encompass Health Corp · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Encompass Health (EHC) Chief Accounting Officer Andrew Price Receives Award

What Happened

  • Andrew L. Price, Chief Accounting Officer of Encompass Health Corp (EHC), received a total of 9,738 restricted shares via two awards: 8,178 shares on 2026-02-18 and 1,560 shares on 2026-02-19. Each award was issued at a $0 acquisition price (typical for restricted stock grants), so the reported cash paid is $0. These were awards/grants (code A), not open-market purchases or sales.

Key Details

  • Transaction dates and amounts:
    • 2026-02-18: 8,178 restricted shares @ $0 (Acquired) — Footnote F1.
    • 2026-02-19: 1,560 restricted shares @ $0 (Acquired) — Footnote F2.
  • Total shares received: 9,738.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes:
    • F1: Issuance resulted from satisfaction of performance criteria tied to a Feb 23, 2023 performance share unit award.
    • F2: Annual restricted stock award under the company's 2025 Omnibus Performance Incentive Plan.
  • Filing: Report filed 2026-02-20 for transactions on 2026-02-18 and 2026-02-19 — appears timely (Form 4 is generally due within two business days).

Context

  • These were restricted stock awards as part of executive compensation, not market purchases or sales. Awards are commonly subject to vesting or other restrictions and do not necessarily indicate immediate buying or selling in the market. The F1 footnote indicates part of the issuance was a performance-based payout from a prior PSU grant; F2 reflects a routine annual grant.

Insider Transaction Report

Form 4
Period: 2026-02-18
Price Andrew L
Chief Accounting Officer
Transactions
  • Award

    Encompass Health Common Stock

    [F1]
    2026-02-18+8,17877,765 total
  • Award

    Encompass Health Common Stock

    [F2]
    2026-02-19+1,56079,325 total
Footnotes (2)
  • [F1]This issuance of restricted stock is the result of the satisfaction performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
  • [F2]Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
Signature
/s/ Patrick Darby, attorney-in-fact for Mr. Price|2026-02-20

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT